Tag: EYLEA

Stock

Regeneron Provides Update on EYLEA HD ® (aflibercept) Injection 8 mg Supplemental Biologics License Application

18/04/2025
admin

Regeneron Provides Update on EYLEA HD ® (aflibercept) Injection 8 mg Supplemental Biologics License Application#Regeneron #Update…

Stock

Three-Year Results for EYLEA HD ® (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended

08/02/2025
admin

Three-Year Results for EYLEA HD ® (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular…